Title : A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).

Pub. Date : 2021 May 13

PMID : 33986418






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Two of these broad-spectrum PRL inhibitors, Salirasib and Candesartan, blocked PRL-3-induced migration in human embryonic kidney cells with no impact on cell viability. candesartan prolactin Homo sapiens